MBST® - the therapy without risk

In the absence of exclusion criteria, MBST® therapy is safe and effective. Some patients report an "agreeable" tingling sensation or a pleasant development of warmth in the area being treated. There is also sometimes a brief increase in pain, an indication of therapeutic success which should not lead to abortion of the treatment.

Treatment device

Magnetic resonance technology has been used for many years in radiology to provide high resolution images to aid diagnosis and treatment. The use of magnetic resonance has not demonstrated any ill effects, making it in fact safer than conventional x-ray imaging.

The therapy is targeted towards damaged cartilage and bone cells. The magnetic resonance fields used in MBST® therapy act exclusively upon damaged cells, in which the energy potential is below normal. This allows these cells to take up the energy provided by MBST® therapy, providing signals for repair and regeneration. Cells with normal energy potentials, and those with higher energy potentials than normal such as malignant cells, do not absorb energy from the MBST® therapy field. These cells have different resonant frequency patterns to the damaged osteoblasts and chondrocytes towards which MBST® therapy is directed. In a recent randomized, double blind trial on human chondrocytes and osteoblasts, Temiz Artmann et al. demonstrated that following 9 hours of MBST treatment, cell proliferation rates were increased with no increase in apoptosis or shortening of cell life spans.

MBST® therapy has been rigorously safety tested and approved for use in the UK and Europe. We are currently awaiting FDA approval for use in the US.

Please see our list of indications and exclusions for more information.